NVO - Novo Nordisk A/S

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5119.23B
Enterprise Value 3122.6B
Trailing P/E 20.79
Forward P/E 118.02
PEG Ratio (5 yr expected) 12.27
Price/Sales (ttm)N/A
Price/Book (mrq)16.63
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 0.76
52-Week Change 312.90%
S&P500 52-Week Change 39.10%
52 Week High 352.83
52 Week Low 341.23
50-Day Moving Average 349.10
200-Day Moving Average 348.84

Share Statistics

Avg Vol (3 month) 31.41M
Avg Vol (10 day) 31.52M
Shares Outstanding 52.41B
Float 1.7B
% Held by Insiders 10.02%
% Held by Institutions 19.41%
Shares Short (May 31, 2019) 42.6M
Short Ratio (May 31, 2019) 41.98
Short % of Float (May 31, 2019) 4N/A
Short % of Shares Outstanding (May 31, 2019) 40.11%
Shares Short (prior month Apr 30, 2019) 42.73M

Dividends & Splits

Forward Annual Dividend Rate 41.25
Forward Annual Dividend Yield 42.44%
Trailing Annual Dividend Rate 31.23
Trailing Annual Dividend Yield 32.39%
5 Year Average Dividend Yield 42.28
Payout Ratio 451.63%
Dividend Date 3Apr 2, 2019
Ex-Dividend Date 4Mar 22, 2019
Last Split Factor (new per old) 21/5
Last Split Date 3Jan 9, 2014

Financial Highlights

Currency in DKK.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 33.56%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)30.09%
Return on Equity (ttm)83.71%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)8.80%
Gross Profit (ttm)94.21B
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)2.46
Quarterly Earnings Growth (yoy)-2.80%

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)9.12
Current Ratio (mrq)0.96
Book Value Per Share (mrq)3.08

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A